ICMR transfers 41 health technologies
Analysis based on 7 articles · First reported May 25, 2026 · Last updated May 26, 2026
The event is expected to boost the biomedical and pharmaceutical sectors in India>>> by accelerating the commercialization of indigenous research. Increased public-private partnerships could lead to new product development and reduced reliance on imported technologies, positively impacting companies involved in healthcare solutions.
The India — Indian Council of Medical Research>>> (ICMR), under the Bangladesh — Ministry of Health and Family Welfare>>>, organized India>>>'s largest biomedical innovation and technology transfer event, 'Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect', in New Delhi. The event saw the transfer of 41 public health technologies, including advanced diagnostics and vaccines for diseases like Typhoid, Paratyphoid, Japanese Encephalitis, Tuberculosis, and Mpox, to various industry partners. This initiative aims to bridge the gap between laboratory research and market-ready healthcare solutions, fostering strong industry partnerships and strengthening India>>>'s biomedical sector. Key figures like Prataprao Jadhav>>> and Dr. Gobardhan Das>>> highlighted India>>>'s ambition to become a global source of affordable and innovative healthcare technologies. The event also marked the establishment of structured platforms for biomedical innovation and the release of the 'Indian Biomedical Patent Landscape Report' and 'Technology Compendium'.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard